🔎 Trials Near Me

Akèy › Kasinom Selil Transizyonèl (Urotelyal) › New York › Queens

Etid klinik pou Kasinom Selil Transizyonèl (Urotelyal) nan Queens, NY

15 etid pou Kasinom Selil Transizyonèl (Urotelyal) ap chèche patisipan nan sit nan ak bò kote Queens (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1
  • START New York Long Island LLC, Lake Success · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06270706

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Ap rekriteFaz 2
  • Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

Ap rekriteEtid obsèvasyon
  • The Feinstein Institutes for Medical Research, Lake Success · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05874921

DBC-664 in Adult Patients With Solid Tumors

Ap rekriteFaz 1
  • START New York, Lake Success · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07705035

Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer

Ap rekriteFaz 2
  • Memorial Sloan Kettering Nassau, Rockville Centre · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT05239624

A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

Ap rekriteFaz 1
  • Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07532902

A Study of GEN1106 in Participants With Solid Tumors

Ap rekriteFaz 1
  • START New York Long Island LLC, Lake Success · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07416123

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Ap rekriteFaz 1
  • NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06293898

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

Ap rekriteFaz 1/2
  • START New York Long Island, New Hyde Park · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07287995

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Ap rekriteFaz 1/2
  • Clinical Research Alliance, Inc, Westbury · 14 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06330064

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Ap rekriteFaz 2
  • MSK nassau, Uniondale · 13 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT04879329

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

Ap rekriteFaz 1
  • Start New York, LLC, Lake Success · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT07484022

A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma

Ap rekriteEtid obsèvasyon
  • Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 29, 2026 · NCT07390617

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer

Ap rekriteFaz 1
  • Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Apr 22, 2026 · NCT05562791

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Hempstead · 12 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kasinom Selil Transizyonèl (Urotelyal) nan lòt vil

Lòt etid nan Queens

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.